Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2014
11/20/2014US20140343070 Proton pump inhibitors
11/20/2014US20140343065 New Somatostatin receptor subtype 4 (SSTR4) agonists
11/20/2014US20140343059 Novel piperazines, pharmaceutical compositions and methods of use thereof
11/20/2014US20140343049 Dihydrofuran derivatives as insecticidal compounds
11/20/2014US20140343038 1,2,4-triazine-6-carboxamide derivative
11/20/2014US20140343032 Novel 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
11/20/2014US20140343029 Novel Imidazole Amines as Modulators of Kinase Activity
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/18/2014US8889880 Processes for preparing tubulysins
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889868 CC-1065 analogs and their conjugates
11/18/2014US8889741 Cycloalkane derivatives
11/18/2014US8889718 Thiazole derivatives
11/18/2014US8889714 3,4-substituted piperidine derivatives as renin inhibitors
11/18/2014US8889713 N-substituted tetrahydroisoquinoline benzamides/benzene sulfonamides as anti-cancer agents
11/18/2014US8889710 Parasiticidal dihydroisoxazole compounds
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889702 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889694 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
11/18/2014US8889691 Indole compounds as an inhibitor of cellular necrosis
11/18/2014US8889690 TRPV1 antagonists including dihydroxy substituent and uses thereof
11/18/2014US8889675 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889670 Heterocyclic compounds which modulate the CB2 receptor
11/18/2014US8889665 Chemical compounds
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889267 Organic light emitting device
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336221 Antibiotic and Anti-Parasitic Agents that Modulate Class II Fructose 1, 6-Bisphosphate Aldolase
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336200 Arylosulfonamides for the treatment of cns diseases
11/13/2014US20140336195 Aryloxmethyl cyclopropane derivatives as pde10 inhibitors
11/13/2014US20140336191 Quinolinyloxyphenylsulfonamides
11/13/2014US20140336190 Benzimidazole derivatives as bromodomain inhibitors
11/13/2014US20140336174 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336168 Nampt inhibitors
11/13/2014US20140336167 Nampt inhibitors
11/11/2014US8884029 Dye for photoelectric conversion device and photoelectric conversion device
11/11/2014US8884025 Processes for the preparation of isothiazole derivatives
11/11/2014US8884013 Polymorphs of Dasatinib, preparation methods and pharmaceutical compositions thereof
11/11/2014US8883954 Photoactive polymers
11/11/2014US8883833 Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
11/11/2014US8883832 Compounds, compositions, and methods for preventing metastasis of cancer cells
11/11/2014US8883828 2-aminopyridine analogs as glucokinase activators
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883824 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/11/2014US8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/11/2014US8883797 Metalloenzyme inhibitor compounds
11/11/2014US8883794 Pharmaceutical composition
11/11/2014US8883793 Tubulin inhibitors and methods of using the same
11/11/2014US8883792 Substituted isoquinoline derivative
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883785 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/11/2014US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/11/2014US8883783 Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
11/11/2014US8883750 Method of treating diabetes
11/11/2014US8883050 Curable colored compositions, color filters and processes for preparing them, liquid crystal display devices, solid-state image sensors, and dye compounds
11/06/2014US20140330011 Certain heterocycles, compositions thereof, and methods for their use
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140329989 Preparation of micafungin intermediates
11/06/2014US20140329863 Novel antiprion compounds
11/06/2014US20140329829 Trpv1 antagonists including dihydroxy substituent and uses thereof
11/06/2014US20140329822 N-piperidin-4-yl derivatives
11/06/2014US20140329821 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
11/06/2014US20140329816 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329801 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
11/06/2014US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
11/06/2014US20140329796 Heterocyclic amide derivative and pharmaceutical product containing same
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/04/2014US8877944 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors
11/04/2014US8877924 Benzyl substituted triazine derivatives and their therapeutical applications
11/04/2014US8877923 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
11/04/2014US8877922 Sweet flavor modifier
11/04/2014US8877804 Sulfur derivatives as chemokine receptor modulators
11/04/2014US8877783 Isoxazolo-pyridine derivatives
11/04/2014US8877782 Isoxazolo-pyridine derivatives
11/04/2014US8877779 Benzimidazole compound and pharmaceutical use thereof
11/04/2014US8877760 Substituted pyrazine-2-carboxamide kinase inhibitors
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
11/04/2014US8877751 Benzothiazolone derivatives
11/04/2014US8877748 Heterocyclic fused anthraquinone derivatives, manufacturing method and pharmaceutical composition using thereof
11/04/2014US8877747 Indenone derivative and pharmaceutical composition comprising same
11/04/2014US8877744 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
11/04/2014US8877741 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
11/04/2014US8877707 Inhibitors of HCV NS5A
10/2014
10/30/2014US20140323736 Use of aryl and hetaryl carboxamides as endoparasiticides
10/30/2014US20140323722 Oxadiazole derivative having endothelial lipase inhibitory activity
10/30/2014US20140323486 Heterocyclic urea compounds
10/30/2014US20140323469 1,4 oxazepines as bace1 and/or bace2 inhibitors
10/30/2014US20140323458 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
10/30/2014US20140323447 Heteroaromatic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
10/30/2014US20140323440 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
10/30/2014US20140323418 Selective kinase inhibitors
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 628